Minnesota Oncology Hematology PA-Maplewood — Maplewood, Minnesota

Minnesota Oncology Hematology PA-Maplewood is a clinical research site located in Maplewood, Minnesota, United States 55109.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology PA-Maplewood has participated in 357 clinical trials with 195 currently active.

Therapeutic areas: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Sponsors: GOG Foundation, National Cancer Institute (NCI), Gynecologic Oncology Group.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology PA-Maplewood?

Minnesota Oncology Hematology PA-Maplewood has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology PA-Maplewood conducted?

Minnesota Oncology Hematology PA-Maplewood has 357 clinical trials on record, with 195 currently active. Their work covers Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Is Minnesota Oncology Hematology PA-Maplewood accredited by Crixeo Health?

Minnesota Oncology Hematology PA-Maplewood has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology Hematology PA-Maplewood?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.